Bone mineral density in long-term depot medroxyprogesterone acetate acceptors
- 1 July 1997
- journal article
- clinical trial
- Published by Elsevier in Contraception
- Vol. 56 (1) , 1-3
- https://doi.org/10.1016/s0010-7824(97)00066-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Alcohol dependence, smoking status, reproductive characteristics, and bone mineral density in premenopausal womenResearch in Nursing & Health, 1996
- Differential effects on bone density of progestogen-only methods for contraception in premenopausal womenContraception, 1995
- Long-acting injectable contraception with depot medroxyprogesterone acetateAmerican Journal of Obstetrics and Gynecology, 1994
- Dual-energy X-ray absorptiometry of the forearm: Reproducibility and correlation with single-photon absorptiometryJournal of Bone and Mineral Research, 1992
- Bone density in women receiving depot medroxyprogesterone acetate for contraception.BMJ, 1991
- Premenopausal Bone Loss — A Risk Factor for OsteoporosisNew England Journal of Medicine, 1990
- Progesterone as a Bone-Trophic HormoneEndocrine Reviews, 1990
- Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis.Journal of Clinical Investigation, 1981
- Serum Medroxyprogesterone Acetate (MPA) Concentrations and Ovarian Function Following Intramuscular Injection of Depo-MPAJournal of Clinical Endocrinology & Metabolism, 1977
- The distribution of cortical and trabecular bone mass along the lengths of the radius and ulna and the implications forin vivo bone mass measurementsCalcified Tissue International, 1976